Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohsen Farsad

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Clinical Nuclear Medicine|November 7, 2009
C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenomaGiulia Magini, Mohsen Farsad, Marta Frigerio, et al.
European Radiology Experimental|June 14, 2022
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnosticsVirginia Liberini, Riccardo Laudicella, Michele Balma, et al.
Nuclear Medicine Communications|July 8, 2005
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretationPaolo Castellucci, Cristina Nanni, Mohsen Farsad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2018
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trialLaura Evangelista, Alberto Cuocolo, Leonardo Pace, et al.
Radiology|July 27, 2007
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CTClaudia Testa, Riccardo Schiavina, Raffaele Lodi, et al.
Haematologica|June 7, 2007
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphomaPier Luigi Zinzani, Monica Tani, Rocco Trisolini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 7, 2018
Risk-related <sup>18</sup>F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trialMarco Spadafora, Leonardo Pace, Laura Evangelista, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2024
A Prospective Randomized Multicenter Study on the Impact of [<sup>18</sup>F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate CancerLaura Evangelista, Fabio Zattoni, Marta Burei, et al.
Clinical Nuclear Medicine|June 20, 2020
10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 PatientsFabio Zattoni, Ilaria Ravelli, Marco Rensi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 9, 2021
Prevalence of interstitial pneumonia suggestive of COVID-19 at <sup>18</sup>F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective studyDomenico Albano, Francesco Bertagna, Pierpaolo Alongi, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical Nuclear Medicine|November 7, 2009
C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenomaGiulia Magini, Mohsen Farsad, Marta Frigerio, et al.
European Radiology Experimental|June 14, 2022
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnosticsVirginia Liberini, Riccardo Laudicella, Michele Balma, et al.
Nuclear Medicine Communications|July 8, 2005
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretationPaolo Castellucci, Cristina Nanni, Mohsen Farsad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2018
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trialLaura Evangelista, Alberto Cuocolo, Leonardo Pace, et al.
Radiology|July 27, 2007
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CTClaudia Testa, Riccardo Schiavina, Raffaele Lodi, et al.
Haematologica|June 7, 2007
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphomaPier Luigi Zinzani, Monica Tani, Rocco Trisolini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 7, 2018
Risk-related <sup>18</sup>F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trialMarco Spadafora, Leonardo Pace, Laura Evangelista, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2024
A Prospective Randomized Multicenter Study on the Impact of [<sup>18</sup>F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate CancerLaura Evangelista, Fabio Zattoni, Marta Burei, et al.
Clinical Nuclear Medicine|June 20, 2020
10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 PatientsFabio Zattoni, Ilaria Ravelli, Marco Rensi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 9, 2021
Prevalence of interstitial pneumonia suggestive of COVID-19 at <sup>18</sup>F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective studyDomenico Albano, Francesco Bertagna, Pierpaolo Alongi, et al.
Pageof 5